
Rare Disease Report: RASRx is the Latest Duchenne Drug To Get Orphan Status…
Read More
CD Access to Provide Special Access Program for Duchenne Muscular Dystrophy Patients in…
Read More
Leader in Cure, Care and Community for Duchenne Muscular Dystrophy CureDuchenne Launches New&he...
Read More
CureDuchenne Applauds the FDA Approval of Marathon’s EMFLAZA (deflazacort) for the Treatment...
Read More